AG
IART icon

Aperio Group’s Integra LifeSciences IART Stock Holding History

Aperio Group’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$1.08M Sell
16,655
-63
-0.4% -$3.39K ﹤0.01% 1554
2020
Q3 		$789K Sell
16,718
-942
-5% -$44.8K ﹤0.01% 1566
2020
Q2 		$830K Buy
17,660
+749
+4% +$36.8K ﹤0.01% 1499
2020
Q1 		$755K Buy
16,911
+2,215
+15% +$116K ﹤0.01% 1424
2019
Q4 		$857K Sell
14,696
-1,324
-8% -$78.8K ﹤0.01% 1509
2019
Q3 		$963K Buy
16,020
+487
+3% +$29K ﹤0.01% 1407
2019
Q2 		$868K Sell
15,533
-1,831
-11% -$94.3K ﹤0.01% 1471
2019
Q1 		$968K Sell
17,364
-790
-4% -$40.2K ﹤0.01% 1385
2018
Q4 		$819K Sell
18,154
-638
-3% -$35K ﹤0.01% 1416
2018
Q3 		$1.24M Sell
18,792
-1,733
-8% -$108K 0.01% 1284
2018
Q2 		$1.32M Sell
20,525
-224
-1% -$13.9K 0.01% 1229
2018
Q1 		$1.15M Buy
20,749
+612
+3% +$32.1K 0.01% 1242
2017
Q4 		$964K Sell
20,137
-1,684
-8% -$82.4K ﹤0.01% 1321
2017
Q3 		$1.1M Buy
21,821
+865
+4% +$44.4K 0.01% 1209
2017
Q2 		$1.14M Buy
20,956
+2,906
+16% +$139K 0.01% 1168
2017
Q1 		$760K Sell
18,050
-13,642
-43% -$583K 0.01% 1298
2016
Q4 		$680K Buy
31,692
+16,894
+114% +$687K 0.01% 1336
2016
Q3 		$611K Buy
14,798
+262
+2% +$11K ﹤0.01% 1337
2016
Q2 		$580K Sell
14,536
-1,024
-7% -$36.8K ﹤0.01% 1311
2016
Q1 		$524K Buy
15,560
+2,784
+22% +$86.7K ﹤0.01% 1342
2015
Q4 		$433K Buy
12,776
+2,740
+27% +$85.6K ﹤0.01% 1414
2015
Q3 		$299K Sell
10,036
-2,040
-17% -$63.8K ﹤0.01% 1565
2015
Q2 		$333K Sell
12,076
-345
-3% -$9.19K ﹤0.01% 1566
2015
Q1 		$313K Buy
12,421
+1,940
+19% +$45.9K ﹤0.01% 1541
2014
Q4 		$232K Buy
+10,481
New +$212K ﹤0.01% 1660

Other funds holding IART

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aperio Group's IART Position: Q4 2020 in Review

Aperio Group reduced its Integra LifeSciences (IART) stake by 0.38% in Q4 2020, selling an estimated $3.39K and leaving 16,655 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #1554.

Aperio Group first reported a position in IART in Q4 2014 and has held it in 25 quarters since. The position peaked at $1.32M in Q2 2018. 251 funds tracked by Wall St. Rank hold IART as of Q4 2020.

  • Aperio Group held 16,655 shares of Integra LifeSciences worth $1.08M as of Q4 2020.
  • Aperio Group sold 63 Integra LifeSciences shares in Q4 2020, an estimated $3.39K.
  • Integra LifeSciences made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #1554 holding.
  • Aperio Group first reported a position in Integra LifeSciences in Q4 2014 and has held it in 25 quarters since.
  • Aperio Group's Integra LifeSciences position peaked at $1.32M in Q2 2018.
  • 251 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.